Roivant Sciences Ltd (87S.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 08:18AM CEST. Market open.
| Previous close | 10.35 |
| Open | 10.21 |
| Bid | 10.21 x N/A |
| Ask | 10.56 x N/A |
| Day's range | 10.21 - 10.21 |
| 52-week range | 7.85 - 12.30 |
| Volume | |
| Avg. volume | 24 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Institutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gain
Key Insights Significantly high institutional ownership implies Roivant Sciences' stock price is sensitive to their...
- Simply Wall St.
Roivant Sciences Third Quarter 2024 Earnings: Beats Expectations
Roivant Sciences ( NASDAQ:ROIV ) Third Quarter 2024 Results Key Financial Results Revenue: US$37.1m (up 118% from 3Q...
- GuruFocus.com
Roivant Sciences Ltd President & COO Eric Venker Sells 96,950 Shares
Eric Venker, President & COO of Roivant Sciences Ltd (NASDAQ:ROIV), executed a sale of 96,950 shares in the company on February 9, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.